loading
Schlusskurs vom Vortag:
$31.68
Offen:
$31.42
24-Stunden-Volumen:
214.10K
Relative Volume:
0.41
Marktkapitalisierung:
$1.77B
Einnahmen:
$651.97M
Nettoeinkommen (Verlust:
$59.71M
KGV:
30.57
EPS:
1.0696
Netto-Cashflow:
$172.03M
1W Leistung:
+0.90%
1M Leistung:
+1.75%
6M Leistung:
+1.44%
1J Leistung:
-1.65%
1-Tages-Spanne:
Value
$31.13
$32.80
1-Wochen-Bereich:
Value
$31.13
$32.87
52-Wochen-Spanne:
Value
$25.53
$40.28

Supernus Pharmaceuticals Inc Stock (SUPN) Company Profile

Name
Firmenname
Supernus Pharmaceuticals Inc
Name
Telefon
301-838-2500
Name
Adresse
9715 KEY WEST AVENUE, ROCKVILLE, MD
Name
Mitarbeiter
674
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
SUPN's Discussions on Twitter

Vergleichen Sie SUPN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
SUPN
Supernus Pharmaceuticals Inc
32.67 1.77B 651.97M 59.71M 172.03M 1.0696
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.26 72.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.96 47.08B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.15 45.99B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.32 17.38B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.87 14.05B 612.78M -86.37M -62.91M -0.87

Supernus Pharmaceuticals Inc Stock (SUPN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-19 Herabstufung Cantor Fitzgerald Overweight → Neutral
2025-01-06 Eingeleitet Cantor Fitzgerald Overweight
2024-09-11 Herabstufung Piper Sandler Overweight → Neutral
2023-01-03 Fortgesetzt Jefferies Buy
2021-12-01 Fortgesetzt Jefferies Buy
2021-04-13 Hochstufung Jefferies Hold → Buy
2020-06-16 Hochstufung Piper Sandler Neutral → Overweight
2020-06-15 Fortgesetzt Jefferies Hold
2019-11-08 Herabstufung Berenberg Buy → Hold
2019-11-07 Herabstufung Stifel Buy → Hold
2019-11-06 Herabstufung Jefferies Buy → Hold
2018-11-12 Bestätigt B. Riley FBR Buy
2018-01-18 Bestätigt B. Riley FBR, Inc. Buy
2017-12-28 Bestätigt B. Riley FBR, Inc. Buy
2017-12-04 Hochstufung Janney Neutral → Buy
2017-11-08 Hochstufung Stifel Hold → Buy
2017-10-19 Eingeleitet FBR & Co. Buy
2017-09-19 Herabstufung Stifel Buy → Hold
2017-07-17 Herabstufung Piper Jaffray Overweight → Neutral
2017-07-14 Eingeleitet Janney Neutral
2017-06-01 Hochstufung Piper Jaffray Neutral → Overweight
2016-07-18 Herabstufung Northland Capital Outperform → Market Perform
2016-07-18 Herabstufung Piper Jaffray Overweight → Neutral
2016-02-08 Hochstufung Jefferies Hold → Buy
2015-11-05 Bestätigt Northland Capital Outperform
2015-10-28 Eingeleitet Northland Capital Outperform
Alle ansehen

Supernus Pharmaceuticals Inc Aktie (SUPN) Neueste Nachrichten

pulisher
06:42 AM

Several Supernus Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal - simplywall.st

06:42 AM
pulisher
04:31 AM

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by HighTower Advisors LLC - Defense World

04:31 AM
pulisher
02:47 AM

Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded by StockNews.com to “Strong-Buy” Rating - Defense World

02:47 AM
pulisher
Mar 31, 2025

An Investigation Has Commenced on Behalf of Supernus Pharmaceuticals, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SUPN Losses. - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Thrivent Financial for Lutherans Sells 591 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Teacher Retirement System of Texas Has $591,000 Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 31, 2025
pulisher
Mar 27, 2025

ATTENTION SUPN SHAREHOLDERS: Investors who lost money on Supernus Pharmaceuticals, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 26, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Swiss National Bank - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Downgraded to “Buy” Rating by StockNews.com - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

11,282 Shares in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Acquired by Proficio Capital Partners LLC - Defense World

Mar 25, 2025
pulisher
Mar 25, 2025

Supernus Pharmaceuticals, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Supernus Pharmaceuticals, Inc. (SUPN) - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 24, 2025

Raymond James Financial Inc. Takes $6.85 Million Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Raymond James Financial Inc. Invests $6.85 Million in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Armenian Reporter

Mar 24, 2025
pulisher
Mar 23, 2025

(SUPN) Trading Report - news.stocktradersdaily.com

Mar 23, 2025
pulisher
Mar 21, 2025

SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your Supernus Pharmaceuticals, Inc. Investment - ACCESS Newswire

Mar 21, 2025
pulisher
Mar 20, 2025

PNC Financial Services Group Inc. Sells 362 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 20, 2025
pulisher
Mar 18, 2025

Atria Investments Inc Invests $288,000 in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

Charles Schwab Investment Management Inc. Purchases 40,968 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround - Yahoo Finance

Mar 17, 2025
pulisher
Mar 16, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded to “Strong-Buy” at StockNews.com - Defense World

Mar 16, 2025
pulisher
Mar 14, 2025

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

Bank of New York Mellon Corp Boosts Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Where are the Opportunities in (SUPN) - news.stocktradersdaily.com

Mar 13, 2025
pulisher
Mar 12, 2025

Smartleaf Asset Management LLC Has $47,000 Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Lost Money on Supernus Pharmaceuticals, Inc. (SUPN)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Proficio Capital Partners LLC Acquires Shares of 11,282 Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) - Defense World

Mar 11, 2025
pulisher
Mar 08, 2025

Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Lowered by StockNews.com - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Supernus Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Spectrum Brands Holdings, Inc. (SPB): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey

Mar 07, 2025
pulisher
Mar 06, 2025

Supernus Pharmaceuticals, Inc. (SUPN): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey

Mar 06, 2025
pulisher
Mar 04, 2025

Supernus to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

CNS Specialist Supernus Sets Investor Conference ScheduleWill You Hear What the CEO Has to Say? - StockTitan

Mar 04, 2025
pulisher
Mar 04, 2025

Lost Money on Supernus Pharmaceuticals, Inc.(SUPN)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 03, 2025

An Investigation Has Commenced on Behalf of Supernus Pharmaceuticals, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your SUPN Losses - accessnewswire.com

Mar 03, 2025
pulisher
Mar 03, 2025

Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals? - Yahoo Finance

Mar 03, 2025
pulisher
Mar 02, 2025

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey

Mar 02, 2025
pulisher
Mar 02, 2025

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stocks to Buy Now? - Yahoo Finance

Mar 02, 2025
pulisher
Mar 02, 2025

(SUPN) Technical Data - Stock Traders Daily

Mar 02, 2025
pulisher
Mar 01, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Principal Financial Group Inc. - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Supernus Pharmaceuticals’ (SUPN) “Neutral” Rating Reiterated at Cantor Fitzgerald - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

StockNews.com Downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) to Buy - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Decoding Supernus Pharmaceuticals Inc (SUPN): A Strategic SWOT I - GuruFocus.com

Feb 28, 2025
pulisher
Feb 28, 2025

12 Best Small Cap Pharma Stocks to Buy Now - Insider Monkey

Feb 28, 2025
pulisher
Feb 27, 2025

Supernus Pharmaceuticals’ Earnings Call Highlights Growth and Challenges - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Supernus to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 27, 2025
pulisher
Feb 27, 2025

What Questions Should Investors Ask Supernus CEO at Upcoming TD Cowen Conference? - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stake Boosted by Rhumbline Advisers - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates - MSN

Feb 27, 2025
pulisher
Feb 26, 2025

Supernus Pharmaceuticals Enters Oversold Territory (SUPN) - Nasdaq

Feb 26, 2025
pulisher
Feb 26, 2025

Supernus Pharmaceuticals Inc (SUPN) Reports Q4 2024 EPS of $0.27 - GuruFocus.com

Feb 26, 2025
pulisher
Feb 26, 2025

Cantor maintains neutral on Supernus, price target at $36 By Investing.com - Investing.com South Africa

Feb 26, 2025

Finanzdaten der Supernus Pharmaceuticals Inc-Aktie (SUPN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Supernus Pharmaceuticals Inc-Aktie (SUPN) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
DEC TIMOTHY C
Senior Vice-President & CFO
Mar 10 '25
Option Exercise
0.00
3,800
0
13,636
Khattar Jack A.
President, CEO
Mar 07 '25
Option Exercise
0.00
38,640
0
992,219
Mottola Frank
SVP, Quality, GMP, Ops, IT
Mar 07 '25
Option Exercise
0.00
2,625
0
16,507
Mottola Frank
SVP, Quality, GMP, Ops, IT
Feb 26 '25
Option Exercise
0.00
5,760
0
17,683
Bhatt Padmanabh P.
Sr. VP of IP, CSO
Feb 21 '25
Option Exercise
0.00
1,650
0
11,799
Rubin Jonathan
SVP, Chief Medical Officer
Feb 21 '25
Option Exercise
0.00
1,875
0
8,780
Rubin Jonathan
SVP, Chief Medical Officer
Feb 21 '25
Sale
39.15
927
36,292
7,853
Mottola Frank
SVP, Quality, GMP, Ops, IT
Feb 21 '25
Option Exercise
0.00
1,125
0
9,576
Bhatt Padmanabh P.
Sr. VP of IP, CSO
Feb 04 '25
Option Exercise
29.61
9,477
280,614
19,626
Bhatt Padmanabh P.
Sr. VP of IP, CSO
Feb 04 '25
Sale
39.70
9,477
376,237
10,149
$32.55
price up icon 0.09%
$97.31
price down icon 0.50%
$8.575
price down icon 0.29%
$107.56
price up icon 0.54%
$312.09
price up icon 1.70%
$131.87
price down icon 0.04%
Kapitalisierung:     |  Volumen (24h):